Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stroke

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.108.532473PMID 19265056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

  2012cited by this paper
• Statins and stroke prevention

  2009cited by this paper
• Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.

  2008cited by this paper
• Effect of Pretreatment With Statins on Ischemic Stroke Outcomes

  2008cited by this paper
• STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE: A CONTROLLED RANDOMIZED STUDY

  2008cited by this paper
• Statin treatment withdrawal in ischemic stroke

  2007cited by this paper
• Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator

  2007cited by this paper
• Statins and Stroke Prevention

  2007cited by this paper
• Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Statins (HMG-CoA Reductase Inhibitors) Decrease Postoperative Adhesions by Increasing Peritoneal Fibrinolytic Activity

  2007cited by this paper
• Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation

  2007cited by this paper
• High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

  2007cited by this paper
• Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators.

  2007cited by this paper
• Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease

  2006cited by this paper
• High-dose atorvastatin after stroke or transient ischemic attack.

  2006cited by this paper
• Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes

  2006cited by this paper
• Discontinuation of Statin Treatment in Stroke Patients

  2006cited by this paper
• Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke

  2006cited by this paper
• Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase

  2006cited by this paper
• Endovascular neuroradiological treatment of acute ischemic stroke: techniques and results in 350 patients

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.

  2005cited by this paper
• Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality

  2005cited by this paper
• Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

  2004cited by this paper
• Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis

  2004cited by this paper
• Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis

  2004cited by this paper
• Short-Term Effect of Low-Dose Atorvastatin on Haemorrheological Parameters, Platelet Aggregation and Endothelial Function in Patients with Cerebrovascular Disease and Hyperlipidaemia

  2004cited by this paper
• Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events.

  2004cited by this paper
• The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients.

  2004cited by this paper
• Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.

  2004cited by this paper
• Rising statin use and effect on ischemic stroke outcome

  2004cited by this paper
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Treatment with Cerivastatin in Primary Mixed Hyperlipidemia Induces Changes in Platelet Aggregation and Coagulation System Components

  2002cited by this paper
• Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion

  2002cited by this paper
• HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins

  2002cited by this paper
• Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis

  2002cited by this paper
• Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.

  2002cited by this paper
• Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation

  2001cited by this paper
• Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project

  2001cited by this paper
• Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor.

  1999cited by this paper
• Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke.

  1999cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.

  1998cited by this paper
• Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study.

  1998cited by this paper
• Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins.

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke.

  1996cited by this paper
• Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.

  1995cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Effects of long-term treatment with lovastatin on the clotting system and blood platelets

  1992cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Measurements of acute cerebral infarction: a clinical examination scale.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• The thrombolysis in myocardial infarction (TIMI) trial.

  1985cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Role of inflammatory biomarkers in mediating the effect of lipids on spontaneous intracerebral hemorrhage: a two-step, two-sample Mendelian randomization study

  2024cites this paper
• Low Levels of Low-Density Lipoprotein Cholesterol Increase the Risk of Post-Thrombectomy Delayed Parenchymal Hematoma

  2023cites this paper
• Associations of lipid profiles with the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis of prospective cohort studies

  2022cites this paper
• The Relationship Between Intracranial Hemorrhage After Intravenous Thrombolytic Therapy and the Need for Antihypertensive Treatment During and After Infusion in Acute Ischemic Stroke

  2022cites this paper
• Statin Therapy for Preventing Recurrent Stroke in Patients with Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies

  2022cites this paper
• Small Unruptured Aneurysm Verification-prevention Effect against Growth of Cerebral Aneurysm Study Using Statin

  2021cites this paper
• Early ischaemic and haemorrhagic complications after atrial fibrillation-related ischaemic stroke: analysis of the IAC study

  2020cites this paper
• The Risk of Symptomatic Intracranial Hemorrhage after Thrombolysis for Acute Stroke: Current Concepts and Perspectives

  2019cites this paper
• Neutrophils in tPA‐induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?

  2019cites this paper
• The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature

  2019cites this paper
• Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis

  2019cites this paper
• Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study

  2019cites this paper
• Statin Treatment in Patients With Intracerebral Hemorrhage

  2018cites this paper
• Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis

  2018cites this paper
• Title : Statins and the risk of intracerebral haemorrhage in stroke patients : Systematic review and meta-analysis

  2018cites this paper
• Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial

  2018cites this paper
• Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post-hoc analysis of the ENCHANTED trial

  2018cites this paper
• Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke

  2018cites this paper
• Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives

  2017cites this paper
• Risks of atrial fibrillation and death at discharge after thrombolysis in stroke patients: Northumbrian Sentinel Stroke Audit, 2013–2015

  2017cites this paper
• Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation.

  2017cites this paper
• Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke

  2017cites this paper
• High‐dose statin therapy and risk of intracerebral hemorrhage: a meta‐analysis

  2016cites this paper
• Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?

  2016cites this paper
• Statin Dose and the Risk of Intracerebral Hemorrhage: A Population-Based Longitudinal Study in Taiwan.

  2016cites this paper
• [Lipids and cerebrovascular disease - New therapeutic options in lowering LDL-cholesterol].

  2016cites this paper
• Efecto de la administración de las estatinas en la patología crítica no cardiológica M. Ruiz-Bailén a, , J. Pérez-Valenzuela b , A. Ferrezuelo-Mata b y R.J. Obra-Cuadra b

  2016cites this paper
• Statin use after intracerebral hemorrhage: a 10‐year nationwide cohort study

  2016cites this paper
• Thrombolysis May Reduce the Incidence/Extent of Postprocedural Ischemic Strokes Associated With Carotid Artery Stenting

  2015cites this paper
• Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke

  2015cites this paper
• Risk Factors for Hemorrhagic Transformation in Patients with Acute Middle Cerebral Artery Infarction.

  2015cites this paper
• Risk of Intracranial Hemorrhage From Statin Use in Asians: A Nationwide Cohort Study

  2015cites this paper
• Statins in Acute Ischemic Stroke: A Systematic Review

  2015influential citation
• Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study

  2015cites this paper
• Statins and intracerebral hemorrhage

  2014cites this paper
• Influence of cognitive impairment on the management of ischaemic stroke.

  2014cites this paper
• Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack

  2014cites this paper
• Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry

  2014cites this paper
• Multimodal CT imaging in acute ischemic stroke

  2014cites this paper
• Trombólise intravenosa para o acidente vascular cerebral isquêmico agudo em um hospital brasileiro, público e acadêmico: caracterização de casuística

  2013cites this paper
• Combining Statins with Tissue Plasminogen Activator Treatment After Experimental and Human Stroke: A Safety Study on Hemorrhagic Transformation

  2013cites this paper
• Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Card

  2013cites this paper
• Cholesterol Levels and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis

  2013cites this paper
• Multisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Card

  2013cites this paper
• Hemorrhage? No! Should Statins Be Paused or Discontinued After Thrombolysis or Acute Intracerebral

  2013cites this paper
• Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines–Stroke

  2013cites this paper
• Should Statins Be Paused or Discontinued After Thrombolysis or Acute Intracerebral Hemorrhage? No!

  2013cites this paper
• Stroke severity and outcomes for octogenarians receiving statins.

  2013cites this paper
• Systematic Review of Methods for Assessing Leptomeningeal Collateral Flow

  2012cites this paper
• Serum cholesterol levels and survival after rtPA treatment in acute stroke

  2012cites this paper
• Systematic Review of Outcome After Ischemic Stroke Due to Anterior Circulation Occlusion Treated With Intravenous, Intra-Arterial, or Combined Intravenous+Intra-Arterial Thrombolysis

  2012cites this paper
• Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital

  2012cites this paper
• Interventional Stroke Therapies in the Elderly: Are We Helping?

  2012cites this paper
• Outcomes after thrombolysis in AIS according to prior statin use

  2012cites this paper
• Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke

  2012cites this paper
• Effect of Serum Lipid Levels on Stroke Outcome after rt-PA Therapy: SAMURAI rt-PA Registry

  2012cites this paper
• Impact of Statin Use and Lipid Profile on Symptomatic Intracerebral Haemorrhage, Outcome and Mortality after Intravenous Thrombolysis in Acute Stroke

  2012cites this paper
• Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia

  2012cites this paper
• Statins in the treatment of acute ischemic stroke.

  2012cites this paper
• Serum Lipids and Statin Treatment During Acute Stroke

  2012influential citation
• The neurovascular unit and combination treatment strategies for stroke.

  2012cites this paper
• Does monitoring of cholesterol levels is required in the acute phase after stroke thrombolysis in statin users

  2012cites this paper
• Rebound effect of drugs: fatal risk of conventional treatment and pharmacological basis of homeopathic treatment

  2012cites this paper
• Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.

  2011cites this paper
• Intracranial Hemorrhage, Outcome, and Mortality After Intra-Arterial Therapy for Acute Ischemic Stroke in Patients Under Oral Anticoagulants

  2011cites this paper
• Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies.

  2011cites this paper
• Effect of the administration of statins in non-cardiac critical disease

  2011cites this paper
• Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis

  2011cites this paper
• Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials

  2011cites this paper
• Intra-Arterial Thrombolysis for Acute Ischemic Stroke in Octogenarians

  2011cites this paper
• Statin use following intracerebral hemorrhage: a decision analysis.

  2011cites this paper
• [Effect of the administration of statins in non-cardiac critical disease].

  2011cites this paper
• Efecto de la administración de las estatinas en la patología crítica no cardiológica

  2011cites this paper
• Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective

  2011cites this paper
• Stroke: Do statins improve outcomes after acute ischemic stroke?

  2011cites this paper
• Influence of Lipid Profiles on the Risk of Hemorrhagic Transformation after Ischemic Stroke: Systematic Review

  2011cites this paper
• Statins Promote the Growth of Experimentally Induced Cerebral Aneurysms in Estrogen-Deficient Rats

  2011cites this paper
• IV thrombolysis and statins

  2011cites this paper
• Cholesterol Levels and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke

  2011cites this paper
• Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases.

  2011cites this paper
• Statins in hemorrhagic stroke

  2011cites this paper
• 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.

  2010cites this paper
• 国内多施設共同登録研究Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry：全体成績とサブ研究の紹介

  2010cites this paper
• rt-PA静注療法施行症例におけるスタチンの頭蓋内出血および転帰におよぼす影響 : Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry

  2010cites this paper
• [Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry].

  2010cites this paper
• Statins and clinical outcome of acute ischemic stroke: a systematic review

  2010cites this paper
• Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?

  2010cites this paper
• Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy

  2010cites this paper
• Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator.

  2010cites this paper
• Statins May Increase Intracerebral Hemorrhage Volume

  2010cites this paper
• Low cholesterol, statin therapy, and intracerebral haemorrhage.

  2009cites this paper
• The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.

  2009cites this paper
• Dyslipidemia as a risk factor for ischemic stroke.

  2009cites this paper
• Thrombolysis by intravenous rt-PA; review of foreign literature

  2009cites this paper